Showing 15,481 - 15,500 results of 42,081 for search '(( 50 ((((mean decrease) OR (we decrease))) OR (a decrease)) ) OR ( a point decrease ))', query time: 0.84s Refine Results
  1. 15481
  2. 15482
  3. 15483
  4. 15484
  5. 15485

    Raw data. by Changzhi Liu (518454)

    Published 2025
    “…This study aimed to explore the association between RC levels and the risk of vertebral fractures in a longitudinal cohort.</p><p>Methods</p><p>A total of 1995 participants aged 50 years or older who underwent chest computed tomography (CT) scans for lung cancer screening between July 2016 and December 2019 were included in this study. …”
  6. 15486
  7. 15487

    Baseline characteristics of the subjects. by Changzhi Liu (518454)

    Published 2025
    “…This study aimed to explore the association between RC levels and the risk of vertebral fractures in a longitudinal cohort.</p><p>Methods</p><p>A total of 1995 participants aged 50 years or older who underwent chest computed tomography (CT) scans for lung cancer screening between July 2016 and December 2019 were included in this study. …”
  8. 15488
  9. 15489

    dPRPS plays a critical function during cellular response to oxidative stress. by Keemo Delos Santos (7349087)

    Published 2019
    “…<p>(A) Ovaries (upper panel) or fat bodies (lower panel) of adult <i>dPRPS GFP-trap</i> flies fed with PBS or PQT are immunostained for GFP (green) and DAPI (blue). …”
  10. 15490

    A Potent Isoprenylcysteine Carboxylmethyltransferase (ICMT) Inhibitor Improves Survival in Ras-Driven Acute Myeloid Leukemia by Nagore I. Marín-Ramos (1600555)

    Published 2019
    “…In this work we report a potent ICMT inhibitor, compound <b>3</b> [UCM-1336, IC<sub>50</sub> = 2 μM], which is selective against the other enzymes involved in the post-translational modifications of Ras. …”
  11. 15491

    A Potent Isoprenylcysteine Carboxylmethyltransferase (ICMT) Inhibitor Improves Survival in Ras-Driven Acute Myeloid Leukemia by Nagore I. Marín-Ramos (1600555)

    Published 2019
    “…In this work we report a potent ICMT inhibitor, compound <b>3</b> [UCM-1336, IC<sub>50</sub> = 2 μM], which is selective against the other enzymes involved in the post-translational modifications of Ras. …”
  12. 15492

    A Potent Isoprenylcysteine Carboxylmethyltransferase (ICMT) Inhibitor Improves Survival in Ras-Driven Acute Myeloid Leukemia by Nagore I. Marín-Ramos (1600555)

    Published 2019
    “…In this work we report a potent ICMT inhibitor, compound <b>3</b> [UCM-1336, IC<sub>50</sub> = 2 μM], which is selective against the other enzymes involved in the post-translational modifications of Ras. …”
  13. 15493

    Trypacidin, a Spore-Borne Toxin from <em>Aspergillus fumigatus</em>, Is Cytotoxic to Lung Cells by Thierry Gauthier (185229)

    Published 2012
    “…Trypacidin was the most toxic, decreasing cell viability and triggering cell lysis, both effects occurring at an IC<sub>50</sub> close to 7 µM. …”
  14. 15494

    Knockdown of nr2f1a causes defects in zebrafish vascular development. by Bao-Jueng Wu (621818)

    Published 2014
    “…At the same stage ISVs are stalled at mid-somite in nr2f1a<sup>e2i2</sup> morphants (<b>D, F</b>). (<b>I</b>) Quantification of percentage of completed ISV shows a50% increase compared to <i>nr2f1a</i> morphants (n = 26 in wt and n = 34 in nr2f1aMO) at 30 hpf. …”
  15. 15495

    Parity and Pancreatic Cancer Risk: A Dose-Response Meta-Analysis of Epidemiologic Studies by Hong-Bo Guan (464993)

    Published 2014
    “…</p><p>Conclusion</p><p>In summary, these findings suggest that higher parity is associated with a decreased risk of PC. Future large consortia or pooled studies are warranted to fully adjust for potential confounders to confirm this association.…”
  16. 15496

    S2 Data - by Tamara Mogilevski (14239682)

    Published 2024
    “…</p><p>Methods</p><p>In a single-blinded, cross-over, randomised study, healthy volunteers received on separate days corticotropin-releasing hormone (CRH, 100 μg) or normal saline (as placebo) intravenously in random order, then a HFHC meal. …”
  17. 15497

    Study protocol. by Tamara Mogilevski (14239682)

    Published 2024
    “…</p><p>Methods</p><p>In a single-blinded, cross-over, randomised study, healthy volunteers received on separate days corticotropin-releasing hormone (CRH, 100 μg) or normal saline (as placebo) intravenously in random order, then a HFHC meal. …”
  18. 15498

    S1 Data - by Tamara Mogilevski (14239682)

    Published 2024
    “…</p><p>Methods</p><p>In a single-blinded, cross-over, randomised study, healthy volunteers received on separate days corticotropin-releasing hormone (CRH, 100 μg) or normal saline (as placebo) intravenously in random order, then a HFHC meal. …”
  19. 15499

    Poincaré maps for the best no-FIC (A1) and post-FIC (B1) MMF fit. by Jan Stasinski (20371167)

    Published 2024
    “…A decrease in number of nodes in a single regime or an increase in the number of nodes in two or three regimes is considered a richer repertoire of behaviors as a result of implementing dFIC.…”
  20. 15500

    Fitted parameter values shown session by session, and at a subsession resolution in the initial and final sessions. by Noémi Éltető (14197656)

    Published 2022
    “…<p>The grey band on the bottom of each plot shows the sequence that participants practiced: the old sequence in sessions 1–8 (dark grey), the new sequence in session 9 (light grey), and both sequences alternately in session 10. Point distance in (a) and cell width in (b) are proportional to data bin size—we fitted the model to 5 epochs within sessions 1, 9, and 10 to assess potentially fast shifts. …”